Zentalis Pharmaceuticals Inc (ZNTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ZNTL | AMGN | VRTX | REGN | BMY |
| Company | Zentalis Pharmaceuticals Inc | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 11.92 | 314.63 | 434.59 | 978.27 | 44.47 |
| High | 12.24 | 315.40 | 438.93 | 978.30 | 44.53 |
| Low | 11.63 | 310.76 | 432.22 | 971.31 | 43.68 |
| Last | 12.03 | 314.69 | 438.10 | 971.72 | 44.01 |
| Change | +0.05 | -2.10 | +0.61 | -6.49 | -0.54 |
| % Change | +0.42% | -0.66% | +0.14% | -0.66% | -1.21% |
| Volume | 82,939 | 1,035,424 | 459,450 | 122,712 | 7,483,330 |
| 20-Day Average Volume | 625,933 | 2,912,344 | 1,081,725 | 447,109 | 14,271,234 |
| Previous Close | 11.98 | 316.79 | 437.49 | 978.21 | 44.55 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 11.90 | 291.40 | 409.77 | 935.30 | 45.28 |
| 20-Day Raw Stochastic | 54.07% | 87.55% | 98.54% | 86.85% | 10.63% |
| 20-Day Relative Strength | 45.67% | 65.58% | 69.44% | 59.78% | 33.75% |
| Weighted Alpha | -33.58 | +40.33 | +30.43 | +29.33 | -34.35 |
| Today's Opinion | 88% Sell | 72% Buy | 72% Buy | 72% Buy | 100% Sell |
| Previous Opinion | 88% Sell | 72% Buy | 56% Buy | 72% Buy | 100% Sell |
| Last Month's Opinion | 56% Sell | 56% Sell | 8% Buy | 24% Buy | 56% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.75% since 05/09/24 | +0.65% since 05/09/24 | +4.67% since 05/09/24 | +0.62% since 05/09/24 | -1.67% since 05/09/24 |
| Low | 11.42 on 05/15/24 | 307.06 on 05/13/24 | 417.50 on 05/10/24 | 966.34 on 05/15/24 | 43.68 on 05/16/24 |
| High | 13.24 on 05/13/24 | 321.44 on 05/15/24 | 439.26 on 05/15/24 | 988.96 on 05/15/24 | 45.72 on 05/14/24 |
| 1-Month | |||||
| %Chg | -6.44% since 04/16/24 | +18.54% since 04/16/24 | +11.26% since 04/16/24 | +8.93% since 04/16/24 | -8.84% since 04/16/24 |
| Low | 10.39 on 04/25/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 43.33 on 05/02/24 |
| High | 13.46 on 04/23/24 | 322.60 on 05/03/24 | 439.26 on 05/15/24 | 988.96 on 05/15/24 | 49.56 on 04/22/24 |
| 3-Month | |||||
| %Chg | -7.09% since 02/16/24 | +10.99% since 02/16/24 | +3.87% since 02/16/24 | +2.74% since 02/16/24 | -11.76% since 02/16/24 |
| Low | 10.39 on 04/25/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 43.33 on 05/02/24 |
| High | 18.07 on 02/28/24 | 322.60 on 05/03/24 | 439.26 on 05/15/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| 6-Month | |||||
| %Chg | +7.40% since 11/16/23 | +17.06% since 11/16/23 | +27.86% since 11/16/23 | +22.28% since 11/16/23 | -13.46% since 11/16/23 |
| Low | 10.05 on 11/28/23 | 260.52 on 11/21/23 | 342.64 on 11/17/23 | 792.57 on 11/28/23 | 43.33 on 05/02/24 |
| High | 18.07 on 02/28/24 | 329.72 on 02/05/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 850,536 | 171,144,224 | 112,895,608 | 107,785,040 | 90,307,296 |
| Shares Outstanding, K | 71,026 | 536,435 | 258,053 | 110,186 | 2,027,100 |
| Annual Sales | 0 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 45,006,000,000 |
| Annual Net Income | -292,190,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 8,025,000,000 |
| Last Quarter Sales | 40,560,000 | 7,447,000,000 | 2,690,600,000 | 3,145,000,000 | 11,865,000,000 |
| Last Quarter Net Income | 10,070,000 | -113,000,000 | 1,099,600,000 | 722,000,000 | -11,911,000,000 |
| 60-Month Beta | 1.82 | 0.60 | 0.39 | 0.17 | 0.45 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.14 on 05/07/24 | 3.96 on 05/02/24 | 4.76 on 05/06/24 | 9.55 on 05/02/24 | -4.40 on 04/25/24 |
| Latest Earnings Date | 05/08/24 | 05/02/24 | 05/06/24 | 05/02/24 | 04/25/24 |
| Most Recent Dividend | N/A | 2.250 on 05/16/24 | N/A | N/A | 0.600 on 04/04/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 04/04/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.72 | 28.46 | 26.53 | 42.58 |